SANA · Sana Biotechnology, Inc.
$3.83
-0.06 (-1.54%)
At close · Sep 3
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has determined that our present capital resources may not be sufficient to fund our planned operations for at least one year from the date of this Quarterly Report, and there is substantial doubt as to our ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Market Cap
$1.15B
Shares
299.36M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-02-18 | CHRISTIAN HORDO & KATHARINE HORDO | Officer | 75,000 | 2025-02-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-01-16 | CHRISTIAN HORDO & KATHARINE HORDO | Officer | 75,000 | 2025-01-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-12-16 | CHRISTIAN HORDO & KATHARINE HORDO JT TEN | Officer | 75,000 | 2024-12-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-11-26 | Hardy Nathan | Former CFO | 91,607 | 2024-11-26 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-11-25 | NATHAN HARDY | Former CFO | 25,933 | 2024-11-25 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-10-21 | NATHAN HARDY | Officer | 45,796 | 2024-10-21 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-09-25 | RICHARD MULLIGAN | Director | 150,000 | 2024-09-25 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-09-24 | RICHARD MULLIGAN | Director | 150,000 | 2024-09-24 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2023-12-15 | CHRISTIAN HORDO & KATHARINE HORDO JT TEN | Officer | 75,000 | 2023-12-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2023-06-07 | Flagship V Venturelabs RX Fund, L.P. | Affiliate | 39,830 | 2023-06-07 | J.P. Morgan Securities LLC |
| 2023-06-07 | FLAGSHIP VENTURES FUND V, L.P. | Affiliate | 310,170 | 2023-06-07 | J.P. Morgan Securities LLC |
| 2023-05-24 | FLAGSHIP VENTURES FUND V, L.P. | affiliate | 85,334 | 2023-05-24 | J.P. Morgan Securities LLC |
| 2023-05-24 | Flagship V Venturelabs RX Fund, L.P. | affiliate | 85,334 | 2023-05-24 | J.P. Morgan Securities LLC |
Showing 1–13 of 13 filings
Key facts
CIK
1770121
CUSIP
799566104
13F (30d)
171 filings
170 filers
Visit website
Investor relations